Cardiovascular Medicine Use Among Adults With ADHD: A Nationwide Study in Australia
Journal of Attention Disorders · 2026-06 · 30 (6) · 773-783
DOI: 10.1177/10870547261418763 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Attention Disorders, online erschienen am 27.03.2026. Verfasst von Masako Araki und 7 weiteren Autor:innen. Beteiligte Einrichtung: UNSW Sydney, Australia. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Cardiovascular Diseases, Cardiovascular Agents. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, European Union – Horizon 2020 Research and Innovation Programme, national heart foundation of australia.
Abstract (Originalsprache)
Background
Despite cardiovascular conditions being common in adults with ADHD, data on patterns of cardiovascular medicine use in this population are scarce.
Methods
Using dispensing claims for a 10% random sample of Australians, this population-based study comprised 14,753 adults with ADHD (defined as having ≥2 ADHD medicine dispensings in 2012–2020) who were 1:4 sex- and age-matched with 59,012 adults without ADHD (no ADHD dispensings). We estimated the prevalence of cardiovascular medicine use in 2021 among adults with and without ADHD, overall and by medicine type, sex, and age. Using Poisson regression, we calculated age- and sex-adjusted prevalence ratios (PRs) with 95% confidence intervals (CIs) to assess associations.
Results
Overall cardiovascular medicine use was more prevalent among adults with ADHD than those without (16.5% vs. 10.0%, aPR = 1.7, 95% CI [1.6, 1.7]), with the highest difference among those aged 18 to 29 years (aPR = 2.8, 95% CI [2.4, 3.1]). We observed increased differences in use of propranolol (3.2% vs. 0.7%), loop diuretics (0.8% vs. 0.4%), potassium-sparing diuretics (0.9% vs. 0.4%), cardiac therapy (0.8% vs. 0.5%), and antithrombotic agents (2.2% vs. 1.4%). Among females, we noted associations of ADHD with specific diuretic subgroups (loop, aPR = 2.8, 95% CI [2.1, 3.7]; potassium-sparing, aPR = 2.5, 95% CI [1.9, 3.3]).
Conclusion
We identified an elevated prevalence of cardiovascular medicine use among adults with ADHD, particularly among younger people. We also observed distinct patterns in specific medicine use between sexes, suggesting potential sex-specific effect modification. Our findings underscore the importance of regular monitoring and management of cardiovascular health among people with ADHD across the lifespan.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UNSW Sydney, Australia.
- University of Iceland, Reykjavík, Iceland.
- Örebro University, Sweden.
- Karolinska Institutet, Stockholm, Sweden.
ORCID-Profile: Masako Araki, Michael O Falster, Juliana de Oliveira Costa
Förderung
- National Health and Medical Research Council
- European Union – Horizon 2020 Research and Innovation Programme
- national heart foundation of australia
- NHMRC Centre of Research Excellence in Medicines Intelligence
- university of new south wales
- National Health and Medical Research Council (NHMRC) – Leadership Grant
- vetenskapsrådet
- Swedish Brain Foundation
Zitieren
APA
Araki, M., Zoega, H., Gillies, M., Falster, M. O., Peiris, D., Pearson, S. A., Larsson, H., & Costa, J. O. (2026). Cardiovascular Medicine Use Among Adults With ADHD: A Nationwide Study in Australia. Journal of Attention Disorders, 30(6), 773-783. https://doi.org/10.1177/10870547261418763
Vancouver
Araki M, Zoega H, Gillies M, Falster MO, Peiris D, Pearson SA, et al. Cardiovascular Medicine Use Among Adults With ADHD: A Nationwide Study in Australia. Journal of Attention Disorders. 2026;30(6):773-783. doi:10.1177/10870547261418763
BibTeX
@article{Araki2026,
author = {Araki, Masako and Zoega, Helga and Gillies, Malcolm and Falster, Michael O and Peiris, David and Pearson, Sallie-Anne and Larsson, Henrik and Costa, Juliana de Oliveira},
title = {Cardiovascular Medicine Use Among Adults With ADHD: A Nationwide Study in Australia},
journal = {Journal of Attention Disorders},
year = {2026},
volume = {30},
number = {6},
pages = {773--783},
doi = {10.1177/10870547261418763}
}
EUVIMED